Emmaus Life Sciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.1M | $-5.9M | $-3.4M | $-2.7M | $-10.9M | $-3.4M | $-8.9M | $-8.2M |
| Depreciation & Amortization | $48.7K | $7.2K | $7.6K | $10.3K | — | — | — | — |
| Depreciation | — | — | — | $10.3K | $13.0K | $18.8K | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.1M | $834.7K | $241.7K | $1.0M | $1.3M | $1.4M | $1.6M | $1.3M |
| Net Cash from Operating Activities | $-4.8M | $-3.0M | $-2.2M | $-3.3M | $-3.0M | $-2.3M | $-3.6M | $-4.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $127.9K | $4.0K | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-479.5K | $-82.3K | — | $0 | $1.4K | $-25.5K | $-21.6K | $-14.9K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.4M | $2.9M | — | $3.3M | $4.3M | $2.6M | $4.2M | $4.0M |
| Net Change in Cash | $5.1M | $-113.9K | $-808.5K | $-33.0K | $1.3M | $-65.9K | $18.2K | $-926.1K |
| Free Cash Flow | $-4.9M | $-3.0M | — | — | — | — | — | — |